Gene tests: who benefits from risk?
- PMID: 8559235
- DOI: 10.1038/379389a0
Gene tests: who benefits from risk?
Abstract
The insurance industry is likely to find it more difficult to use genetic data on disease susceptibility than some of its critics claim. But it is already contesting demands for strict controls on the way this data is used.
Comment in
-
Genes, patents and insurance.Nature. 1996 Feb 22;379(6567):672. doi: 10.1038/379672c0. Nature. 1996. PMID: 8602207 No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
